Jessica S Wang Memoli1, Ezzat El-Bayoumi2, Nicholas J Pastis3, Nichole T Tanner3, Mario Gomez4, J Terrill Huggins3, Georgiana Onicescu5, Elizabeth Garrett-Mayer5, Kent Armeson5, Katherine K Taylor3, Gerard A Silvestri6. 1. Section of Pulmonary, Critical Care, and Respiratory Services, Washington Hospital Center, Washington, DC. 2. Palmetto Pulmonary and Critical Care Associates, Greenville, SC. 3. Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Medical University of South Carolina, Charleston, SC. 4. Pulmonary and Sleep Center of the Valley, Weslaco, TX. 5. Department of Medicine, Division of Biostatistics and Epidemiology, Medical University of South Carolina, Charleston, SC. 6. Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Medical University of South Carolina, Charleston, SC. Electronic address: silvestr@musc.edu.
Abstract
PURPOSES: Reliable staging of the mediastinum determines TNM classification and directs therapy for non-small cell lung cancer (NSCLC). Our aim was to evaluate predictors of mediastinal lymph node metastasis in patients undergoing endobronchial ultrasound (EBUS). METHODS: Patients with known or suspected lung cancer undergoing EBUS for staging were included. Lymph node radiographic characteristics on chest CT/PET scan and ultrasound characteristics of size, shape, border, echogenicity, and number were correlated with rapid on-site evaluation (ROSE) and final pathology. Logistic regression (estimated with generalized estimating equations to account for correlation across nodes within patients) was used with cancer (vs normal pathology) as the outcome. ORs compare risks across groups, and testing was performed with two-sided α of 0.05. RESULTS: Two hundred twenty-seven distinct lymph nodes (22.5% positive for malignancy) were evaluated in 100 patients. Lymph node size, by CT scan and EBUS measurements, and round and oval shape were predictive of mediastinal metastasis. Increasing size of lymph nodes on EBUS was associated with increasing malignancy risk (P = .0002). When adjusted for CT scan size, hypermetabolic lymph nodes on PET scan did not predict malignancy. Echogenicity and border contour on EBUS and site of biopsy were not significantly associated with cancer. In 94.8% of lymph nodes with a clear diagnosis, the ROSE of the first pass correlated with subsequent passes. CONCLUSIONS: Lymph node size on CT scan and EBUS and round or oval shape by EBUS are predictors of malignancy, but no single characteristic can exclude a visualized lymph node from biopsy. Further, increasing the number of samples taken is unlikely to significantly improve sensitivity.
PURPOSES: Reliable staging of the mediastinum determines TNM classification and directs therapy for non-small cell lung cancer (NSCLC). Our aim was to evaluate predictors of mediastinal lymph node metastasis in patients undergoing endobronchial ultrasound (EBUS). METHODS:Patients with known or suspected lung cancer undergoing EBUS for staging were included. Lymph node radiographic characteristics on chest CT/PET scan and ultrasound characteristics of size, shape, border, echogenicity, and number were correlated with rapid on-site evaluation (ROSE) and final pathology. Logistic regression (estimated with generalized estimating equations to account for correlation across nodes within patients) was used with cancer (vs normal pathology) as the outcome. ORs compare risks across groups, and testing was performed with two-sided α of 0.05. RESULTS: Two hundred twenty-seven distinct lymph nodes (22.5% positive for malignancy) were evaluated in 100 patients. Lymph node size, by CT scan and EBUS measurements, and round and oval shape were predictive of mediastinal metastasis. Increasing size of lymph nodes on EBUS was associated with increasing malignancy risk (P = .0002). When adjusted for CT scan size, hypermetabolic lymph nodes on PET scan did not predict malignancy. Echogenicity and border contour on EBUS and site of biopsy were not significantly associated with cancer. In 94.8% of lymph nodes with a clear diagnosis, the ROSE of the first pass correlated with subsequent passes. CONCLUSIONS: Lymph node size on CT scan and EBUS and round or oval shape by EBUS are predictors of malignancy, but no single characteristic can exclude a visualized lymph node from biopsy. Further, increasing the number of samples taken is unlikely to significantly improve sensitivity.
Authors: Gonzalo V Gonzalez-Stawinski; Anthony Lemaire; Faisal Merchant; Elizabeth O'Halloran; R Edward Coleman; David H Harpole; Thomas A D'Amico Journal: J Thorac Cardiovasc Surg Date: 2003-12 Impact factor: 5.209
Authors: Michael B Wallace; James Ravenel; Mark I Block; Mostafa Fraig; Gerard Silvestri; Stephan Wildi; Nathan Schmulewitz; Shyam Varadarajulu; Stacey Roberts; Brenda J Hoffman; Robert H Hawes; Carolyn E Reed Journal: Ann Thorac Surg Date: 2004-05 Impact factor: 4.330
Authors: Nathan Schmulewitz; Stephan M Wildi; Shyam Varadarajulu; Stacey Roberts; Robert H Hawes; Brenda J Hoffman; Valerie Durkalski; Gerard A Silvestri; Mark I Block; Carolyn Reed; Michael B Wallace Journal: Gastrointest Endosc Date: 2004-02 Impact factor: 9.427
Authors: Christian Jenssen; Jouke Tabe Annema; Paul Clementsen; Xin-Wu Cui; Mathias Maximilian Borst; Christoph Frank Dietrich Journal: J Thorac Dis Date: 2015-10 Impact factor: 2.895
Authors: M Elizabeth Wilcox; M Patricia Rivera; Catherine Sassoon; Lorraine B Ware; Hannah Wunsch; Margaret S Herridge Journal: Proc Am Thorac Soc Date: 2012-10
Authors: Christoph F Dietrich; Christian Jenssen; Paolo G Arcidiacono; Xin-Wu Cui; Marc Giovannini; Michael Hocke; Julio Iglesias-Garcia; Adrian Saftoiu; Siyu Sun; Liliana Chiorean Journal: Endosc Ultrasound Date: 2015 Jul-Sep Impact factor: 5.628
Authors: Roel L J Verhoeven; Fausto Leoncini; Jorik Slotman; Chris de Korte; Rocco Trisolini; Erik H F M van der Heijden Journal: Respiration Date: 2021-06-24 Impact factor: 3.580